Euronext
Carlyle in exclusive talks to buy Arriva for £2.16bn – report
Advent International, I Squared Capital and Apollo Management have also indicated their interested
PAI sells 9% Atos stake
GP sold 9.2 million shares for a total of €581.9m
Sigma-backed Relaxnews sold to Publicis
Relaxnews listed on the NYSE Alternext in 2011
AAC grants overallotment option in Lucas Bols IPO
AAC raised €17m through sale of extra 1 million shares
VC-backed Bone Therapeutics raises €32m in IPO
Dual listing gives company a market cap of €104.8m
VC-backed Bone Therapeutics to list
Company could raise up to €28.8m at the top end of the indicative price range
Eurazeo’s Elis launches IPO
Eurazeo bought Elis in 2007 for €2.276bn
AAC’s Lucas Bols to float
AAC currently owns a 75% stake in the business
PE-backed Spie launches IPO
Company's shareholders plan to sell 21.6 million shares
VC-backed Viadeo raises €24.4m in IPO
Company received €5m investment from A Capital just last week
Bain’s IMCD sets IPO price range
Bain retains significant shareholding post-IPO
VC-backed arGEN-X announces IPO plans
Plans to offer new shares to raise fresh funding for company
VC-backed Anevia raises €7.3m in IPO
IPO oversubscribed by 4.3x
VC-backed Fermentalg raises €40m in IPO
Flotation valued the business at €106.9m
CVC fully exits bpost
CVC Capital Partners has sold the remainder of its shares in Belgian postal service bpost, which listed on the NYSE Euronext Brussels earlier this year, for €580m.
PAI sells Atos stake for €545m
PAI partners has divested a 9% stake in its portfolio company Atos, a listed French IT services provider, for €545m in a private placement.
Advent offers €1bn to take Unit4 private
Advent International has put in a €1.17bn offer to take Dutch software company Unit4 private in a deal that would value the whole business at €1.28bn.
Activa buys majority stake in listed Nexeya
Activa Capital has acquired a 57.9% stake in NYSE Euronext-listed Nexeya, alongside BPI France Investissement, and launched an offer for the remainder of the shares.
Gimv and Iris Capital sell stake in Human Inference
Gimv and Iris Capital have sold their share of Dutch data management solutions provider Human Inference to French trade buyer Neopost.
Cinven and Warbug Pincus exercise Ziggo over-allotment option
Cinven, Warburg Pincus and their co-investors have announced the initiation of an over-allotment option for Dutch cable operator Ziggo.
Advent to take Mediq private for €775m
Advent International has announced plans to delist Dutch pharma company Mediq from the Euronext Amsterdam, valuing the company at €775m.
HarbourVest NAV registers slight drop in July
HarbourVest Global Private Equity has announced an estimated net asset value (NAV) of $935.4m at 31 July 2012.
Waterland PE backs Omega Pharma take-private
Waterland Private Equity has backed the take private of over-the-counter pharmaceuticals company Omega Pharma.
Agri Investment Fund CVBA invests in PinguinLutosa
Agri Investment Fund (AIF) has acquired KBC Private Equity’s stake in listed Belgian frozen vegetables specialist PinguinLutosa in a deal thought to be worth around €8.5m.